Skip to contentSkip to filters

We use cookies for analytics.

Topic: positron emission tomography

Seminar
4 seminars

In Brain Imaging and Clinical Neurology

Seminar · Brain Imaging

From aura to neuroinflammation: Has imaging resolved the puzzle of migraine pathophysiology?

Nouchine Hadjikhani · Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston and Gillberg Neuropsychiatry Center, Sahlgrenska Academy, University of Gothenburg, Sweden

Thu, Nov 18, 2021 · 16:00 UTC

In this talk I will present data from imaging studies that we have been conducting for the past 20 years trying to shed light on migraine physiopathology, from anatomical and functional MRI to positron emission tomography.

Seminar · Biochemistry

Blood phosphorylated tau as biomarkers for Alzheimer’s disease

Thomas K. Karikari · University of Gothenburg

Thu, Dec 10, 2020 · 15:00 UTC

Alzheimer's disease (AD) is the most common cause of dementia, and its health and socioeconomic burdens are of major concern. Presently, a definite diagnosis of AD is established by examining brain tissue after death. These examinations focus on two major pathological hallmarks of AD in the brain: (i) amyloid plaques consisting of aggregated amyloid beta (Aβ) peptides and (ii) neurofibrillary tangles made of abnormally phosphorylated tau protein. In living individuals, AD diagnosis relies on two main approaches: (i) brain imaging of tau tangles and Aβ plaques using a technique called positron

Seminar · Brain Imaging

Multimodal brain imaging to predict progression of Alzheimer’s disease

Karl Herholz · University of Manchester, Division of Neuroscience and Experimental Psychology

Mon, Dec 7, 2020 · 11:00 UTC

Cross-sectional and longitudinal multimodal brain imaging studies using positron emission tomography (PET) and magnetic resonance imaging (MRI) have provided detailed insight into the pathophysiological progression of Alzheimer’s disease. It starts at an asymptomatic stage with widespread gradual accumulation of beta-amyloid and spread of pathological tau deposits. Subsequently changes of functional connectivity and glucose metabolism associated with mild cognitive impairment and brain atrophy may develop. However, the rate of progression to a symptomatic stage and ultimately dementia varies c

Seminar · Medical Imaging

Development and Application of PET Imaging for Dementia Research

Franklin Aigbirhio · University of Cambridge

Tue, Nov 3, 2020 · 15:00 UTC

Molecular imaging using Positron Emission Tomography (PET) has become a major biomedical imaging technology. Its application towards characterisation of biochemical processes in disease could enable early detection and diagnosis, development of novel therapies and treatment evaluation. The technology is underpinned by the use of imaging probes radiolabelled with short-lived radioisotopes which can be specific and selective for biological targets in vivo e.g. markers for receptors, protein deposits, enzymes and metabolism. My talk will focus on the increasing development and application of PET